Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.80 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | RARB | P10826 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12461806 | 1.00 | L3MBTL1 (0.80) | L3MBTL1PLA2G4BKMT2AMEN1FFAR4 | |
| SCHEMBL1806524 | 0.89 | L3MBTL1 (1.00) | L3MBTL1KMT2AMEN1FFAR4LMNA | |
| SCHEMBL12224513 | 0.84 | L3MBTL1 (0.56) | L3MBTL1PLA2G4BKMT2AMEN1FFAR4 | |
| SCHEMBL12224519 | 0.84 | L3MBTL1 (0.56) | L3MBTL1PLA2G4BKMT2AMEN1FFAR4 | |
| SCHEMBL12223524 | 0.84 | PKM (0.56) | L3MBTL1ALDH1A1 | |
| SCHEMBL5638782 | 0.84 | PKM (0.56) | L3MBTL1ALDH1A1 | |
| SCHEMBL6883728 | 0.84 | L3MBTL1 (0.82) | L3MBTL1PLA2G4BKMT2AMEN1FFAR4 | |
| SCHEMBL13401600 | 0.83 | L3MBTL1 (0.64) | L3MBTL1PLA2G4BLMNARARBRAB9A | |
| SCHEMBL4239666 | 0.83 | DRD2 (0.57) | L3MBTL1LMNANPC1HPGDALDH1A1 | |
| SCHEMBL12570291 | 0.83 | DRD2 (0.57) | L3MBTL1LMNANPC1HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4328270-A2 | ULTRAVIOLET ABSORBING POLYMERIC DYES AND METHODS FOR USING THE SAME | Becton, Dickinson and Company (US) | 2024-02-28 | — | — | EP | disclosed |
| US-20180074066-A1 | Novel Reagents for Directed Biomarker Signal Amplification | SIRIGEN GROUP LIMITED (GB) | 2018-03-15 | — | — | US | disclosed |
| US-20170174892-A1 | PHOTOSTABLE FLUORESCENT POLYMERIC TANDEM DYES INCLUDING LUMINESCENT METAL COMPLEXES | BECTON, DICKINSON AND COMPANY | 2017-06-22 | — | — | US | disclosed |
| US-8575303-B2 | Reagents for directed biomarker signal amplification | SIRIGEN GROUP LIMITED (GB) | 2013-11-05 | — | — | US | disclosed |
| US-8362193-B2 | Reagents for directed biomarker signal amplification | SIRIGEN GROUP LIMITED (GB) | 2013-01-29 | — | — | US | disclosed |
| US-20110256550-A1 | Novel reagents for directed biomarker signal amplification | SIRIGEN, INC. (US) | 2011-10-20 | — | — | US | disclosed |
| US-20110257374-A1 | Novel Reagents for Directed Biomarker Signal Amplification | SIRIGEN, INC. (US) | 2011-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180074066-A1 | Novel Reagents for Directed Biomarker Signal Amplification | RNGTT, CAPG, CD2BP2 | L3MBTL1 3469/4885PLA2G4B 338/4885KMT2A 4432/4885 |
| US-20110257374-A1 | Novel Reagents for Directed Biomarker Signal Amplification | RNGTT, CAPG, CD2BP2 | L3MBTL1 3469/4885PLA2G4B 338/4885KMT2A 4432/4885 |
| US-20110256550-A1 | Novel reagents for directed biomarker signal amplification | RNGTT, CAPG, CD2BP2 | L3MBTL1 3469/4885PLA2G4B 338/4885KMT2A 4432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.